PACAP – Neuropeptide, Migraine & Function
PACAP (Pituitary Adenylate Cyclase-Activating Polypeptide) is an endogenous neuropeptide with key roles in the nervous and endocrine systems, notably involved in migraine attacks and the regulation of stress responses.
Things worth knowing about "PACAP"
PACAP (Pituitary Adenylate Cyclase-Activating Polypeptide) is an endogenous neuropeptide with key roles in the nervous and endocrine systems, notably involved in migraine attacks and the regulation of stress responses.
What is PACAP?
PACAP (Pituitary Adenylate Cyclase-Activating Polypeptide) is an endogenous neuropeptide – a small protein molecule that acts as a chemical messenger in the nervous system. First isolated in 1989 from the ovine hypothalamus, it belongs to the secretin/glucagon superfamily of peptides. PACAP exists in two biologically active forms: PACAP-38 (38 amino acids) and PACAP-27 (27 amino acids). PACAP-38 is the predominant form found in the human body.
Distribution in the Body
PACAP is widely distributed throughout the human body and is found in particular in:
- Central nervous system (brain and spinal cord)
- Peripheral nervous system
- Hypothalamus and pituitary gland
- Adrenal medulla
- Gastrointestinal tract
- Reproductive organs
- Immune cells
Mechanism of Action
PACAP exerts its effects by binding to specific cell surface receptors. Three receptor subtypes have been identified:
- PAC1 receptor: binds PACAP exclusively with high affinity
- VPAC1 receptor: binds both PACAP and the related peptide VIP (Vasoactive Intestinal Peptide)
- VPAC2 receptor: also binds both PACAP and VIP
Upon receptor binding, PACAP primarily activates the cAMP signaling pathway (cyclic adenosine monophosphate), triggering a wide range of cellular responses including vasodilation, neuroprotection, and the release of additional signaling molecules.
Biological Functions
PACAP fulfills numerous important roles throughout the body:
- Neurotransmitter and neuromodulator: Modulates the transmission of nerve signals
- Neuroprotective effects: Protects nerve cells from programmed cell death (apoptosis) during injury or disease
- Regulation of the stress response: Plays a key role in activating the stress axis (HPA axis) and the release of stress hormones such as cortisol
- Vasodilation: Dilates blood vessels, particularly those in the brain
- Regulation of sleep and circadian rhythms
- Immunomodulation: Influences inflammatory responses
- Hormone secretion: Stimulates the release of various pituitary hormones
PACAP and Migraine
One of the most intensively studied aspects of PACAP is its role in migraine. Research has demonstrated that intravenous infusion of PACAP-38 can trigger typical migraine attacks in patients with a history of migraine. Elevated plasma levels of PACAP-38 have been detected during spontaneous migraine attacks.
The vasodilatory effect of PACAP on cranial blood vessels and the activation of the trigeminovascular system (a key pain-processing network in the brain) are considered central mechanisms in migraine pathophysiology. This has positioned PACAP as a promising therapeutic target for new migraine treatments. Monoclonal antibodies targeting either the PAC1 receptor or PACAP itself are currently being investigated in clinical trials for migraine prevention.
PACAP and Psychiatric Disorders
Emerging research suggests that PACAP may also play a role in anxiety disorders, post-traumatic stress disorder (PTSD), and depression. Alterations in PACAP signaling have been linked to stress processing, particularly in women, which may partly explain the higher prevalence of PTSD in females.
PACAP in Medical Research
Due to its wide-ranging effects, PACAP is being actively investigated as a potential therapeutic agent for various conditions, including:
- Neurodegenerative diseases (e.g., Parkinson's disease, Alzheimer's disease)
- Stroke (neuroprotective effects)
- Inflammatory bowel disease
- Diabetes (influence on insulin secretion)
- Migraine (receptor blockade as a therapeutic target)
References
- Vaudry, D. et al. (2009): Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery of the Neuropeptide. Pharmacological Reviews, 61(3), 283–357. PubMed PMID: 19805477.
- Ashina, M. et al. (2012): PACAP38 induces migraine-like attacks in patients with migraine without aura. Cephalalgia, 32(15), 1116–1123. PubMed PMID: 22906677.
- Ressler, K.J. et al. (2011): Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor. Nature, 470(7335), 492–497. PubMed PMID: 21350482.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryVitamin A K D
Water retention analysis
Jejunal mucosal markers
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: PACAP